Human Vγ9Vδ2 T cells: From signals to functions

Seminars in Immunology

Volumn 22, Issue 4, 2010, Pages 199-206

  Nedellec, Steven ^a   Bonneville, Marc ^a   Scotet, Emmanuel ^a  

^a INSERM   (France)

Author keywords

Co stimulation; Functions; Human gamma delta T cells; Signal transduction; T cell receptor

Indexed keywords

FC RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL KILLER CELL RECEPTOR; T CELL RECEPTOR VDELTA2, HUMAN; T CELL RECEPTOR VGAMMA9, HUMAN; T-CELL RECEPTOR VDELTA2, HUMAN; T-CELL RECEPTOR VGAMMA9, HUMAN;

ADAPTIVE IMMUNITY; CELL PROLIFERATION; CELL SURFACE; CYTOTOXICITY; DNA DAMAGE; HUMAN; IMMUNOLOGICAL SYNAPSE; IMMUNOREGULATION; INNATE IMMUNITY; NATURAL KILLER T CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; V GAMMA 9V DELTA T LYMPHOCYTE; ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE;

ANIMALS; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, NATURAL KILLER CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77955670236     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2010.04.004     Document Type: Review

References (63)

1. Hayday A.C. [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000, 18:975-1026.
2. Hayday A.C. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 2009, 31:184-196.
3. Constant P., Davodeau F., Peyrat M.A., Poquet Y., Puzo G., Bonneville M., et al. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 1994, 264:267-270.
4. Tanaka Y., Morita C.T., Nieves E., Brenner M.B., Bloom B.R. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 1995, 375:155-158.
5. Gober H.J., Kistowska M., Angman L., Jeno P., Mori L., De Libero G. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003, 197:163-168.
6. Sireci G., Espinosa E., Di Sano C., Dieli F., Fournie J.J., Salerno A. Differential activation of human gammadelta cells by nonpeptide phosphoantigens. Eur J Immunol 2001, 31:1628-1635.
7. Altincicek B., Moll J., Campos N., Foerster G., Beck E., Hoeffler J.F., et al. Cutting edge: human gamma delta T cells are activated by intermediates of the 2-C-methyl-d-erythritol 4-phosphate pathway of isoprenoid biosynthesis. J Immunol 2001, 166:3655-3658.
8. Espinosa E., Belmant C., Pont F., Luciani B., Poupot R., Romagne F., et al. Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells. J Biol Chem 2001, 276:18337-18344.
9. Morita C.T., Beckman E.M., Bukowski J.F., Tanaka Y., Band H., Bloom B.R., et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 1995, 3:495-507.
10. Allison T.J., Winter C.C., Fournie J.J., Bonneville M., Garboczi D.N. Structure of a human gammadelta T-cell antigen receptor. Nature 2001, 411:820-824.
11. Kunzmann V., Bauer E., Feurle J., Weissinger F., Tony H.P., Wilhelm M. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000, 96:384-392.
12. Thompson K., Rojas-Navea J., Rogers M.J. Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood 2006, 107:651-654.
13. Kato Y., Tanaka Y., Miyagawa F., Yamashita S., Minato N. Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens. J Immunol 2001, 167:5092-5098.
14. Kato Y., Tanaka Y., Tanaka H., Yamashita S., Minato N. Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate. J Immunol. 2003, 170:3608-3613.
15. Scotet E., Martinez L.O., Grant E., Barbaras R., Jeno P., Guiraud M., et al. Ecto-F1-ATPase and MHC-class I close association on cell membranes. Immunity. 2005, 22:71-80.
16. Vantourout P., Mookerjee-Basu J., Rolland C., Pont F., Martin H., Davrinche C., et al. Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen J Immunol. 2009, 183:3848-3857.
17. Vantourout P., Martinez L.O., Fabre A., Collet X., Champagne E., Ecto-F1-ATPase, MHC-class I close association on cell membranes. Mol Immunol. 2008, 45:485-492.
18. Appleman L.J., Boussiotis V.A. T cell anergy and costimulation. Immunol Rev. 2003, 192:161-180.
19. Carding S.R., Egan P.J., Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol. 2002, 2:336-345.
20. Wang P., Malkovsky M. Different roles of the CD2 and LFA-1 T-cell co-receptors for regulating cytotoxic, proliferative, and cytokine responses of human V gamma 9/V delta 2 T cells. Mol Med. 2000, 6:196-207.
21. Kato Y., Tanaka Y., Hayashi M., Okawa K., Minato N. Involvement of CD166 in the Activation of Human {gamma}{delta}T Cells by Tumor Cells Sensitized with Nonpeptide Antigens. J Immunol. 2006, 177:877-884.
22. Springer T.A., Dustin M.L., Kishimoto T.K., Marlin S.D. The lymphocyte function-associated LFA-1. CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol. 1987, 5:223-252.
23. Castro M.A., Nunes R.J., Oliveira M.I., Tavares P.A., Simoes C., Parnes J.R., et al. OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylation. J Leukoc Biol. 2003, 73:183-190.
24. Hassan N.J., Simmonds S.J., Clarkson N.G., Hanrahan S., Puklavec M.J., Bomb M., et al. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76. Mol Cell Biol. 2006, 26:6727-6738.
25. Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D.H., Rae1 H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 2001, 413:165-171.
26. Girardi M., Oppenheim D.E., Steele C.R., Lewis J.M., Glusac E., Filler R., et al. Regulation of cutaneous malignancy by gammadelta T cells. Science. 2001, 294:605-609.
27. Lopez-Larrea C., Suarez-Alvarez B., Lopez-Soto A., Lopez-Vazquez A., Gonzalez S. The NKG2D receptor: sensing stressed cells. Trends Mol Med. 2008, 14:179-189.
28. Marusina A.I., Burgess S.J., Pathmanathan I., Borrego F., Coligan J.E. Regulation of human DAP10 gene expression in NK and T cells by Ap-1 transcription factors. J Immunol. 2008, 180:409-417.
29. Das H., Groh V., Kuijl C., Sugita M., Morita C.T., Spies T., et al. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity. 2001, 15:83-93.
30. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA. 1999, 96:6879-6884.
31. Corvaisier M., Moreau-Aubry A., Diez E., Bennouna J., Mosnier J.F., Scotet E., et al. V gamma 9V delta 2 T cell response to colon carcinoma cells. J Immunol. 2005, 175:5481-5488.
32. Todaro M., D'Asaro M., Caccamo N., Iovino F., Francipane M.G., Meraviglia S., et al. Efficient killing of human colon cancer stem cells by {gamma}{delta} T Lymphocytes. J Immunol. 2009, 182:7287-7296.
33. Wrobel P., Shojaei H., Schittek B., Gieseler F., Wollenberg B., Kalthoff H., et al. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol. 2007, 66:320-328.
34. Kunzmann V., Wilhelm M. Anti-lymphoma effect of gammadelta T cells. Leuk Lymphoma. 2005, 46:671-680.
35. Lanca T., Correia D.V., Moita C.F., Raquel H., Neves-Costa A., Ferreira C., et al. The MHC class Ib protein ULBP1 is a non-redundant determinant of leukemia/lymphoma susceptibility to {gamma}{delta} T-cell cytotoxicity. Blood. 2010, 115:2407-2411.
36. Kong Y., Cao W., Xi X., Ma C., Cui L., He W. The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D. Blood. 2009, 114:310-317.
37. Rincon-Orozco B., Kunzmann V., Wrobel P., Kabelitz D., Steinle A., Herrmann T. Activation of Vgamma9Vdelta2 T cells by NKG2D. J Immunol. 2005, 175:2144-2151.
38. Nedellec S, Sabourin C, Bonneville M, Scotet E., NKG2D costimulates human Vgamma2Vdelta2 T cell antitumor cytotoxicity through PKCtheta-dependent modulation of early TCR-induced calcium and transduction signals. J Immunol. 2010; in press.
39. von Lilienfeld-Toal M., Nattermann J., Feldmann G., Sievers E., Frank S., Strehl J., et al. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells. Clin Exp Immunol. 2006, 144:528-533.
40. Toutirais O., Cabillic F., Le Friec G., Salot S., Loyer P., Le Gallo M., et al. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. Eur J Immunol. 2009, 39:1361-1368.
41. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005, 17:1-14.
42. Beetz S., Wesch D., Marischen L., Welte S., Oberg H.H., Kabelitz D. Innate immune functions of human gammadelta T cells. Immunobiology. 2008, 213:173-182.
43. Pietschmann K., Beetz S., Welte S., Martens I., Gruen J., Oberg H.H., et al. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes. Scand J Immunol. 2009, 70:245-255.
44. Wesch D., Beetz S., Oberg H.H., Marget M., Krengel K., Kabelitz D. Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes. J Immunol. 2006, 176:1348-1354.
45. Devilder M.C., Allain S., Dousset C., Bonneville M., Scotet E. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells. J Immunol. 2009, 183:3625-3633.
46. Shojaei H., Oberg H.H., Juricke M., Marischen L., Kunz M., Mundhenke C., et al. Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells. Cancer Res. 2009, 69:8710-8717.
47. Angelini D.F., Borsellino G., Poupot M., Diamantini A., Poupot R., Bernardi G., et al. FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood. 2004, 104:1801-1807.
48. Lafont V., Liautard J., Liautard J.P., Favero J. Production of TNF-alpha by human Vgamma9Vdelta2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen. J Immunol. 2001, 166:7190-7199.
49. Smith-Garvin J.E., Koretzky G.A., Jordan M.S. T cell activation. Annu Rev Immunol. 2009, 27:591-619.
50. Favier B., Espinosa E., Tabiasco J., Dos Santos C., Bonneville M., Valitutti S., et al. Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes. J Immunol. 2003, 171:5027-5033.
51. Chen Y., Shao L., Ali Z., Cai J., Chen Z.W. NSOM/QD-based nanoscale immunofluorescence imaging of antigen-specific T-cell receptor responses during an in vivo clonal V{gamma}2V{delta}2 T-cell expansion. Blood. 2008, 111:4220-4232.
52. Krangel M.S., Bierer B.E., Devlin P., Clabby M., Strominger J.L., McLean J., et al. T3 glycoprotein is functional although structurally distinct on human T-cell receptor gamma T lymphocytes. Proc Natl Acad Sci U S A. 1987, 84:3817-3821.
53. Siegers G.M., Swamy M., Fernandez-Malave E., Minguet S., Rathmann S., Guardo A.C., et al. Different composition of the human and the mouse gammadelta T cell receptor explains different phenotypes of CD3gamma and CD3delta immunodeficiencies. J Exp Med. 2007, 204:2537-2544.
54. Lanzavecchia A. Understanding the mechanisms of sustained signaling and T cell activation. J Exp Med. 1997, 185:1717-1719.
55. Genot E., Cantrell D.A. Ras regulation and function in lymphocytes. Curr Opin Immunol. 2000, 12:289-294.
56. Hayashi K., Altman A. Protein kinase C theta (PKCtheta): a key player in T cell life and death. Pharmacol Res. 2007, 55:537-544.
57. Oh-hora M., Rao A. Calcium signaling in lymphocytes. Curr Opin Immunol. 2008, 20:250-258.
58. Lafont V., Liautard J., Sable-Teychene M., Sainte-Marie Y., Favero J. Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human gamma delta T lymphocytes without inducing eown-modulation of T cell antigen receptor. J Biol Chem. 2001, 276:15961-15967.
59. Cipriani B., Knowles H., Chen L., Battistini L., Brosnan C.F. Involvement of classical and novel protein kinase C isoforms in the response of human Vgamma9Vdelta2 T cells to phosphate antigens. J Immunol. 2002, 169:5761-5770.
60. Correia D.V., d'Orey F., Cardoso B.A., Lanca T., Grosso A.R., deBarros A., et al. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells. PLoS One. 2009, 4:e5657.
61. Wei H., Huang D., Lai X., Chen M., Zhong W., Wang R., et al. Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta2 TCR. J Immunol. 2008, 181:4798-4806.
62. Lafont V., Loisel S., Liautard J., Dudal S., Sable-Teychene M., Liautard J.P., et al. Specific signaling pathways triggered by IL-2 in human Vgamma9Vdelta2 T cells: an amalgamation of NK and alpha beta T cell signaling. J Immunol. 2003, 171:5225-5232.
63. Carena I., Shamshiev A., Donda A., Colonna M., Libero G.D. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands. J Exp Med. 1997, 186:1769-1774.